BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18186036)

  • 1. Variations in hospitalisation costs for acute myocardial infarction - a comparison across Europe.
    Tiemann O
    Health Econ; 2008 Jan; 17(1 Suppl):S33-45. PubMed ID: 18186036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A micro-costing approach to estimating hospital costs for appendectomy in a cross-European context.
    Schreyögg J
    Health Econ; 2008 Jan; 17(1 Suppl):S59-69. PubMed ID: 18186034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health service costs in Europe: cost and reimbursement of primary hip replacement in nine countries.
    Stargardt T
    Health Econ; 2008 Jan; 17(1 Suppl):S9-20. PubMed ID: 18186038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ; Scuffham PA; McCollam PL; Newby DE
    Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost and reimbursement of cataract surgery in Europe: a cross-country comparison.
    Fattore G; Torbica A
    Health Econ; 2008 Jan; 17(1 Suppl):S71-82. PubMed ID: 18186033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hospital costs of care for stroke in nine European countries.
    Epstein D; Mason A; Manca A
    Health Econ; 2008 Jan; 17(1 Suppl):S21-31. PubMed ID: 18186037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What can we learn from a cross-country comparison of the costs of child delivery?
    Bellanger MM; Or Z
    Health Econ; 2008 Jan; 17(1 Suppl):S47-57. PubMed ID: 18186035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-country comparisons of costs: the use of episode-specific transitive purchasing power parities with standardised cost categories.
    Schreyögg J; Tiemann O; Stargardt T; Busse R
    Health Econ; 2008 Jan; 17(1 Suppl):S95-103. PubMed ID: 18186031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of reimbursement changes for intracoronary stents on providers and Medicare.
    Vaitkus PT
    Am J Manag Care; 1998 Aug; 4(8):1097-102. PubMed ID: 10182885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European comparison of costs and quality in the treatment of acute myocardial infarction (2000-2001).
    Gandjour A; Kleinschmit F; Lauterbach KW;
    Eur Heart J; 2002 Jun; 23(11):858-68. PubMed ID: 12042007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and prices of single dental fillings in Europe: a micro-costing study.
    Tan SS; Ken Redekop W; Rutten FF
    Health Econ; 2008 Jan; 17(1 Suppl):S83-93. PubMed ID: 18186032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sources of hospital cost variability.
    Dormont B; Milcent C
    Health Econ; 2004 Oct; 13(10):927-39. PubMed ID: 15386688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain.
    Ray JA; Valentine WJ; Secnik K; Oglesby AK; Cordony A; Gordois A; Davey P; Palmer AJ
    Curr Med Res Opin; 2005 Oct; 21(10):1617-29. PubMed ID: 16238902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Attempt to exclude invasive cardiology services in Poland--rationing, national sovereignty and European Union law].
    Gericke CA; Busse R; Sakowska I; Kuszewski K; Maciag A
    Przegl Epidemiol; 2006; 60(2):323-9. PubMed ID: 16964685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience with primary coronary angioplasty in management of patients suffering from acute myocardial infarction].
    Maslov LN; Krylov AL
    Angiol Sosud Khir; 2008; 14(1):131-41. PubMed ID: 19156043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs of providing antiplatelet medication for percutaneous coronary intervention patients.
    Carroll NW; Dorsch MP
    Am J Manag Care; 2011 Dec; 17(12):803-10. PubMed ID: 22216751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The marginal benefits of invasive treatments for acute myocardial infarction: does insurance coverage matter?
    Brooks JM; McClellan M; Wong HS
    Inquiry; 2000; 37(1):75-90. PubMed ID: 10892359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Assessment of the cost of the curative treatment of myocardial infarction in the Abidjan Cardiology Institute].
    Konin C; Ekra A; Adoh A; Kohou L; Avodagbé A; Niamkey T; N'djessan J
    Bull Soc Pathol Exot; 2007 Aug; 100(3):201-4. PubMed ID: 17824316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focus on facts: acute stenting for STEMIs.
    Wilson D
    Circulation; 2006 Mar; 113(10):f38-9. PubMed ID: 16538724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.